PepsiCo Reportedly Preparing Snack Price Hikes for Late June
Britains Energy Shock Editorial Warns MiniMeasures Insufficient Amid Iran Conflict
Jim Cramer Urges Focus on Future Upside in AI Stocks Highlights Corning Example
Trump Asks Supreme Court to Halt TikTok Ban Sending Ripples Through Tech Sector
Russias Renewed Strikes on Kyiv Escalate Geopolitical Tensions Potential Market Implications
Anthropic Nears 1 Trillion Valuation After 65 Billion Series H Overtaking OpenAI
CING Q1 2026 Earnings Deep EPS Miss Overshadowed by Positive Stock Movement
GPMT Q1 2026 Earnings NarrowerThanExpected Loss Drives Positive Surprise
EVH Q1 2026 Earnings EPS Surpasses Expectations with 614 Surprise
CELC Q1 2026 Earnings NarrowerThanExpected Loss Highlights Progress but Stock Slips
KVYO Q1 2026 Earnings EPS Beat Amidst Modest Stock Decline
ProQR Therapeutics Q1 2026 Earnings Narrower Net Loss No Revenue as Pipeline Progress Drives Stock Gains
Algoma Steel Group ASTL Holds Steady at 473 as Traders Eye Key Resistance and Support Levels
Red Cat Holdings RCAT Climbs 351 as Drone Sector Sentiment Strengthens
Frontdoor Inc FTDR Holds Steady Near Support as Market Watches for Breakout
Immunovant IMVT Holds Steady Near Support as Biotech Sector Faces Headwinds
Calamos Convertible and High Income Fund CHY Approaches Key Resistance After 189 Gain
Spotify Gains Attention as Steve Cohen Portfolio Holding
Xtant Medical Holdings Inc XTNT Q1 2026 Earnings EPS Misses Estimates Amidst Narrow Loss
PVH Corp PVH Bounces 255 From Support Testing NearTerm Resistance
ICFI Q1 2026 Earnings EPS Slightly Misses Estimates Stock Rises on Positive Market Sentiment
SPS Commerce Q1 2026 Earnings EPS Surprises to the Upside as Operating Discipline Supports Bottom Line
Bank of Marin Bancorp BMRC Q1 2026 Earnings EPS Falls Short of Estimates Amid Challenging Landscape
EVLV Q1 2026 Earnings Narrow Loss Surprise Lifts Shares
NCSM Q1 2026 Earnings Significant EPS Miss Despite Slight Stock Rise
SVM Q1 2026 Earnings Strong EPS Beat Highlights Silver and Cost Management Gains
BioXcel Therapeutics BTAI Q1 2026 Earnings EPS Misses Expectations as PreRevenue Biotech Focuses on Pipeline Progress